{
    "2019-12-06": [
        [
            {
                "time": "",
                "original_text": "“时光荏苒，星堡守候”走进星堡中环养老社区，体验一站式综合性养老",
                "features": {
                    "keywords": [
                        "养老社区",
                        "星堡",
                        "综合性养老"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "养老产业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药股回暖反弹，金斯瑞涨超4%",
                "features": {
                    "keywords": [
                        "医药股",
                        "金斯瑞",
                        "反弹"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "带量采购开标至今，都对药企造成了哪些影响？",
                "features": {
                    "keywords": [
                        "带量采购",
                        "药企",
                        "影响"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中生制药涨逾2% 重上10天及100天线",
                "features": {
                    "keywords": [
                        "中生制药",
                        "上涨",
                        "均线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "薪酬过亿上市药企高管已达3位！抢人才 本土创新药企与MNC拼待遇",
                "features": {
                    "keywords": [
                        "薪酬",
                        "药企高管",
                        "本土创新药企",
                        "MNC"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "人力资源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-09",
                "original_text": "【民生医药|周报】12/09：集采政策加快推进，稳妥加仓优势赛道",
                "features": {
                    "keywords": [
                        "集采政策",
                        "民生医药",
                        "周报",
                        "加仓",
                        "优势赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-05",
                "original_text": "智通港股通持股解析|12月5日",
                "features": {
                    "keywords": [
                        "港股通",
                        "持股解析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "港股市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "复星医药原研药仿制药审评均获进展 业绩增长有戏？",
                "features": {
                    "keywords": [
                        "复星医药",
                        "原研药",
                        "仿制药",
                        "审评进展",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股开盘前瞻：小米斥2亿港元回购2202万股 小摩增持中国人保",
                "features": {
                    "keywords": [
                        "港股",
                        "小米",
                        "回购",
                        "小摩",
                        "增持",
                        "中国人保"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}